Bangalore: The Open Source Drug Discovery (OSDD) program, a Council of Scientific and Industrial Research (CSIR) initiat...
Singapore: The resulting merger will generate revenues close to $406 million and will have a product pipeline of more th...
Singapore: India-based Zydus Cadila has launched the biosimilar of Adalimumab, indicated for the treatment of auto immun...
Singapore: Pharmaceutical companies will suffer an estimated $65 billion drop in sales by 2019 worldwide due to the pate...
Singapore: In this newly created position, Ms Monge will focus on sharpening SSB's profile as an integrated solution pro...
Singapore: Indian drug giant, Dr Reddy's laboratories recently announced collaboration with Australia's Hatchtech, a pha...
Mumbai: NATCO Pharma has filed a lawsuit against Mr Shamnaad Basheer, professor, West Bengal National University of Juri...
Singapore: Type 2 diabetes treatment market in Asia-Pacific (APAC) will rise in value from an estimated $6.5 billion in ...
Bangalore: AstraZeneca has revealed that it will shut down its Bangalore-based Avishkar R&D center and slash 170 job...
Singapore: Fortis healthcare announced that it has inked a deal to sell its entire diagnostic and molecular imaging unit...
Singapore: "Despite rumors," said Dr Poonam Singh, "there have been no confirmed cases of Ebola in the eleven countries ...
Singapore: Addressing the 70th foundation day function of Indian Institute of Chemical Technology (IICT), Dr Jitendra Si...
Singapore: Requesting the government to consider keeping clinical trials services out of the ambit of service tax, the t...
Singapore: Indian drugmaker, Strides Arcolab, has announced that it has received approval from the United States Food a...
Singapore: Ongoing hearing of public interest litigation (PIL) filed by an NGO, Swasthya Adhikar Manch, that was suppose...
Singapore: Close to 120,402 tele-consultations to rural communities in UP and Bihar, India, has been delivered by the Wo...
Singapore: Ahead of the India next week on September 4, the Australian High Commissioner in New Delhi, Mr. Patrick Suckl...
AstraZeneca took the national biotech community by surprise by its sudden announcement on January 30, 2014, that it will...
